SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-050090
Filing Date
2020-09-11
Accepted
2020-09-11 08:28:58
Documents
2
Period of Report
2020-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1608
2 POA DOCUMENT poa.txt EX-24.3_936753 3578
  Complete submission text file 0001209191-20-050090.txt   6590
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Issuer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 1520 NEW YORK NY 10016
Business Address
Carson William H. (Reporting) CIK: 0001824280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38939 | Film No.: 201169998